来源:药渡撰文:Pharmadeep编辑:维他命2025年7月8日,基石药业宣布与意大利百年药企Istituto Gentili达成独家战略合作,共同推动抗PD-L1单抗药物舒格利单抗在西欧和英国市场的商业化进程。根据协议,基石药业有望获得最高达1.925亿美元(约合人民币13.8亿元)的总交易金额,并将享有授权区域内近50%的净销售额分成。此次合作覆盖包括英国、德国、法国、意大利等在内的23个...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.